ID stringlengths 13 17 | question stringlengths 88 1.13k | answer stringlengths 6 156 | reference_sequence stringlengths 4.1k 4.1k | variant_sequence stringlengths 4.1k 4.1k |
|---|---|---|---|---|
Task1_train_12700 | A variant affecting Chromosome 9, within the gene CDKN2A (cyclin dependent kinase inhibitor 2A), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Melanoma-pancreatic cancer syndrome | ATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAGCCAGGGAGTTTGAGGCTGCAGTGAGCTGTGATCGCGCCACTGCACTCCAGGTTGGGCAACAGATCGACTCTGTCTCCAAATGTAAACCCCATGAGGGCAAGACTCTTGTTTGGTCTCATTCACCTTGGCGTGCCCACCACCTAGAACAGGGCTGATCACGCA... | ATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAGCCAGGGAGTTTGAGGCTGCAGTGAGCTGTGATCGCGCCACTGCACTCCAGGTTGGGCAACAGATCGACTCTGTCTCCAAATGTAAACCCCATGAGGGCAAGACTCTTGTTTGGTCTCATTCACCTTGGCGTGCCCACCACCTAGAACAGGGCTGATCACGCA... |
Task1_train_12701 | A mutation on Chromosome 9 affecting CDKN2A (cyclin dependent kinase inhibitor 2A) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Melanoma and neural system tumor syndrome | ATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAGCCAGGGAGTTTGAGGCTGCAGTGAGCTGTGATCGCGCCACTGCACTCCAGGTTGGGCAACAGATCGACTCTGTCTCCAAATGTAAACCCCATGAGGGCAAGACTCTTGTTTGGTCTCATTCACCTTGGCGTGCCCACCACCTAGAACAGGGCTGATCACGCA... | ATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAGCCAGGGAGTTTGAGGCTGCAGTGAGCTGTGATCGCGCCACTGCACTCCAGGTTGGGCAACAGATCGACTCTGTCTCCAAATGTAAACCCCATGAGGGCAAGACTCTTGTTTGGTCTCATTCACCTTGGCGTGCCCACCACCTAGAACAGGGCTGATCACGCA... |
Task1_train_12702 | This is a variant in PLAA (phospholipase A2 activating protein), located on Chromosome 9. Is this mutation a likely cause of disease or not? | Pathogenic; Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | TACTTTTGTATTCAGAAAAAACATTAAGAGAATCATAGGAAAGTTTAACTAAAAAAGAAAATCTTTAAAATATCATTAAATTATTTAACATATCCTTCAAGTGAGATTGTTTCCTTTTGCTAAGCTATATTTTGTAATCTCCACAACAAACATGAAATAGTAAAGTTGACATAAAAAAACTTGCACAGTAATAGGAAGCAGTGTTTACATTTTGCCACCCCTTACATTTTGAAGAGGGAACTCATATTCTTAACCAAGACTGTTTCTTATCATTATTCAAAGGTACCTACTTTTCCTAAATATTGCAATTAAATTATTTG... | TACTTTTGTATTCAGAAAAAACATTAAGAGAATCATAGGAAAGTTTAACTAAAAAAGAAAATCTTTAAAATATCATTAAATTATTTAACATATCCTTCAAGTGAGATTGTTTCCTTTTGCTAAGCTATATTTTGTAATCTCCACAACAAACATGAAATAGTAAAGTTGACATAAAAAAACTTGCACAGTAATAGGAAGCAGTGTTTACATTTTGCCACCCCTTACATTTTGAAGAGGGAACTCATATTCTTAACCAAGACTGTTTCTTATCATTATTCAAAGGTACCTACTTTTCCTAAATATTGCAATTAAATTATTTG... |
Task1_train_12703 | Mutation context: Chromosome 9, Gene PLAA (phospholipase A2 activating protein). Determine if this variant is likely to be benign or pathogenic. Mention the disease if applicable. | Pathogenic; Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | GCTATGTTGGCCAGACTGGTCTTGAACTCCTGACCTTGTGATCTGCCTGCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTCAGCCACCACACCTGGCCTGATAATTCTATTTAAATCAACATGCAGGTAACATTAGTTTTATTTTATGAATGGGCAATGAAATTTTGAAGTAGAATGAGGAGATAATTTGGGAATGTGGAGTAGCTGTCAGGGAAGAAAAGGTGGATCTACATAAGGATTTGAGACAGGAATATAATACAAAGTCCTCGTAAAACAAGGAAGAGCACTAGCACCTGAAAAATGTTGAGTCAGAAATG... | GCTATGTTGGCCAGACTGGTCTTGAACTCCTGACCTTGTGATCTGCCTGCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTCAGCCACCACACCTGGCCTGATAATTCTATTTAAATCAACATGCAGGTAACATTAGTTTTATTTTATGAATGGGCAATGAAATTTTGAAGTAGAATGAGGAGATAATTTGGGAATGTGGAGTAGCTGTCAGGGAAGAAAAGGTGGATCTACATAAGGATTTGAGACAGGAATATAATACAAAGTCCTCGTAAAACAAGGAAGAGCACTAGCACCTGAAAAATGTTGAGTCAGAAATG... |
Task1_train_12704 | The gene PLAA (phospholipase A2 activating protein) on Chromosome 9 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | ATGTTTGGATTAGATGGCCGTCCTTAACCTCTTTTCTCAGAAAAATTACTTTATCTCCATGATTTCTTAATTCGAAATTCTGAGATAGGAGAAGCAAATTAGACACTTCCAACTGTATTAATCCTGGCCCATTCTACAGGAAACCTGTTTCTAACTTATTCGTCCACAAACATGTACATCACTCGTTCTATTGGTTTTTCTTCATATGCTTAGGAGGGAAAAAAACTAAGCCTATAAATCAGCCTCTGTCCCAGCCAAAAAATAAAACACCCACTTTATTAGACCCTCTATCCCTTATAGCTGTCACCTTCTTTTTCTTC... | ATGTTTGGATTAGATGGCCGTCCTTAACCTCTTTTCTCAGAAAAATTACTTTATCTCCATGATTTCTTAATTCGAAATTCTGAGATAGGAGAAGCAAATTAGACACTTCCAACTGTATTAATCCTGGCCCATTCTACAGGAAACCTGTTTCTAACTTATTCGTCCACAAACATGTACATCACTCGTTCTATTGGTTTTTCTTCATATGCTTAGGAGGGAAAAAAACTAAGCCTATAAATCAGCCTCTGTCCCAGCCAAAAAATAAAACACCCACTTTATTAGACCCTCTATCCCTTATAGCTGTCACCTTCTTTTTCTTC... |
Task1_train_12705 | Given a variant located on Chromosome 9 and affecting PLAA (phospholipase A2 activating protein), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | CCAACACTGGGAGGCCAAGGTGGGCAGATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTAGCCGGGCATGGTGGCACATGCCTGTAATCACAGCTTCTTGGGAGGCTGAGGCAAGAGAATCGCTTGAACCCCGGAGGCGGAGGTTGCAGTGAGCCAAGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAGCAAAACTCTGTCTCAAAAAAAAAAAATCAATAGTTCAATGAACAACAAAATCACTTTTCAAATAGAGAATCAGTTCAGCCCAAA... | CCAACACTGGGAGGCCAAGGTGGGCAGATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTAGCCGGGCATGGTGGCACATGCCTGTAATCACAGCTTCTTGGGAGGCTGAGGCAAGAGAATCGCTTGAACCCCGGAGGCGGAGGTTGCAGTGAGCCAAGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAGCAAAACTCTGTCTCAAAAAAAAAAAATCAATAGTTCAATGAACAACAAAATCACTTTTCAAATAGAGAATCAGTTCAGCCCAAA... |
Task1_train_12706 | A variant was discovered in gene PLAA (phospholipase A2 activating protein), Chromosome 9. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | CCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTAGCCGGGCATGGTGGCACATGCCTGTAATCACAGCTTCTTGGGAGGCTGAGGCAAGAGAATCGCTTGAACCCCGGAGGCGGAGGTTGCAGTGAGCCAAGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAGCAAAACTCTGTCTCAAAAAAAAAAAATCAATAGTTCAATGAACAACAAAATCACTTTTCAAATAGAGAATCAGTTCAGCCCAAAGTTCTTCAAGTTCCTGGTAAGCACAACCACTCCAGTGATTAAACCCTTGTCA... | CCAGCCTGACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTAGCCGGGCATGGTGGCACATGCCTGTAATCACAGCTTCTTGGGAGGCTGAGGCAAGAGAATCGCTTGAACCCCGGAGGCGGAGGTTGCAGTGAGCCAAGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAGCAAAACTCTGTCTCAAAAAAAAAAAATCAATAGTTCAATGAACAACAAAATCACTTTTCAAATAGAGAATCAGTTCAGCCCAAAGTTCTTCAAGTTCCTGGTAAGCACAACCACTCCAGTGATTAAACCCTTGTCA... |
Task1_train_12707 | A sequence alteration has been identified in IFT74 (intraflagellar transport 74) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; Spermatogenic failure 58 | GGGTGACTGAAGACCTCTTCTTGAAGGAGAATGGGAATCCCCGACAAGCCCCCAGAATTGTTAGAAAGAAAGCTTGAAGTCGTAAAGAAAGACGAGTACTCAAACAAAGGATTTCTCAGCAAAGCAAATTTACTTTTGCGCAGTAGGGTGCTTCTTACAGGGCTGCTTGTCATGAGAGCACACTGAAGAAAGTAGAGTAGAAGCTTTTATTCCTAATGTGACTCCTGCCCTCGTGCCCTTTCCCCATTGGCTGGGGTCGGACTGCACAATCTAAACTAGACCCAATTGGCTAAACATTTAAACTTTCTTAGATAAGGTGG... | GGGTGACTGAAGACCTCTTCTTGAAGGAGAATGGGAATCCCCGACAAGCCCCCAGAATTGTTAGAAAGAAAGCTTGAAGTCGTAAAGAAAGACGAGTACTCAAACAAAGGATTTCTCAGCAAAGCAAATTTACTTTTGCGCAGTAGGGTGCTTCTTACAGGGCTGCTTGTCATGAGAGCACACTGAAGAAAGTAGAGTAGAAGCTTTTATTCCTAATGTGACTCCTGCCCTCGTGCCCTTTCCCCATTGGCTGGGGTCGGACTGCACAATCTAAACTAGACCCAATTGGCTAAACATTTAAACTTTCTTAGATAAGGTGG... |
Task1_train_12708 | This sequence change occurs on Chromosome 9, altering TEK (TEK receptor tyrosine kinase). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Multiple cutaneous and mucosal venous malformations | ATTACAACCCTGTGAGTCAGACTCATCTCCACTGAGTTTGGAATATAAATGAGTAGCCCGAGGTCATATAGTGGTTAGGTGGCAGGGTTAAGGCTGCTGTTAAGTTCCCATTACACTGTGTCTTCTCCCACATACGGTGTGGGTCTGTTTCTCTATGTAAACTAAACTACCTGCTTCACCTCTGTCTTCCTGCACAGCACCAGCGGACCTCGGAGGGGGGAAGATGCTGCTTATAGCCATCCTTGGCTCTGCTGGAATGACCTGCCTGACTGTGCTGTTGGCCTTTCTGATCATATTGCAATTGAAGAGGGCAAATGTGC... | ATTACAACCCTGTGAGTCAGACTCATCTCCACTGAGTTTGGAATATAAATGAGTAGCCCGAGGTCATATAGTGGTTAGGTGGCAGGGTTAAGGCTGCTGTTAAGTTCCCATTACACTGTGTCTTCTCCCACATACGGTGTGGGTCTGTTTCTCTATGTAAACTAAACTACCTGCTTCACCTCTGTCTTCCTGCACAGCACCAGCGGACCTCGGAGGGGGGAAGATGCTGCTTATAGCCATCCTTGGCTCTGCTGGAATGACCTGCCTGACTGTGCTGTTGGCCTTTCTGATCATATTGCAATTGAAGAGGGCAAATGTGC... |
Task1_train_12709 | Consider this mutation in TEK (TEK receptor tyrosine kinase) on Chromosome 9. Is this a benign change or a disease-causing variant? | Pathogenic; Segmental undergrowth associated with venous malformation without capillary component | ATTACAACCCTGTGAGTCAGACTCATCTCCACTGAGTTTGGAATATAAATGAGTAGCCCGAGGTCATATAGTGGTTAGGTGGCAGGGTTAAGGCTGCTGTTAAGTTCCCATTACACTGTGTCTTCTCCCACATACGGTGTGGGTCTGTTTCTCTATGTAAACTAAACTACCTGCTTCACCTCTGTCTTCCTGCACAGCACCAGCGGACCTCGGAGGGGGGAAGATGCTGCTTATAGCCATCCTTGGCTCTGCTGGAATGACCTGCCTGACTGTGCTGTTGGCCTTTCTGATCATATTGCAATTGAAGAGGGCAAATGTGC... | ATTACAACCCTGTGAGTCAGACTCATCTCCACTGAGTTTGGAATATAAATGAGTAGCCCGAGGTCATATAGTGGTTAGGTGGCAGGGTTAAGGCTGCTGTTAAGTTCCCATTACACTGTGTCTTCTCCCACATACGGTGTGGGTCTGTTTCTCTATGTAAACTAAACTACCTGCTTCACCTCTGTCTTCCTGCACAGCACCAGCGGACCTCGGAGGGGGGAAGATGCTGCTTATAGCCATCCTTGGCTCTGCTGGAATGACCTGCCTGACTGTGCTGTTGGCCTTTCTGATCATATTGCAATTGAAGAGGGCAAATGTGC... |
Task1_train_12710 | Given this variant in gene TEK (TEK receptor tyrosine kinase) on Chromosome 9, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Vascular malformation | ATCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGG... | ATCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGG... |
Task1_train_12711 | Chromosome 9 houses a mutation in gene TEK (TEK receptor tyrosine kinase). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Blue rubber bleb nevus | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... |
Task1_train_12712 | A variant has been detected on Chromosome 9 in TEK (TEK receptor tyrosine kinase). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Ventricular septal defect | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... |
Task1_train_12713 | The following genetic variant occurs in TEK (TEK receptor tyrosine kinase) on Chromosome 9. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Multiple cutaneous and mucosal venous malformations | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... | TCTTGAGGTTACGTTTACTTCATCTGGTTGCAGTTGGTCTTTAGGGAGAGAATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGG... |
Task1_train_12714 | This sequence variant lies in TEK (TEK receptor tyrosine kinase) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Vascular malformation | AATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGA... | AATAAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGA... |
Task1_train_12715 | Given a variant located on Chromosome 9 and affecting TEK (TEK receptor tyrosine kinase), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Vascular malformation | AAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGAGAA... | AAACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGAGAA... |
Task1_train_12716 | This gene mutation involves TEK (TEK receptor tyrosine kinase) on Chromosome 9. Is it associated with any clinical condition, or is it benign? | Pathogenic; not provided | AACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGAGAAT... | AACCATGATATTAATGCAGCTTCCTTCTTGGGAAAAAAAACCACAACAACAAAAATATATCCCTTAAAATTTTGCTTCGTCATCACATTAGCACATAGCTGGCTCTTAAAATTTTAAGATAGGCCGGGCGTGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAAGGTCAAGATGTCGAGACCATCCTGGCCAACCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAACTGGGCCTAGTGGCGCATGCCTGTAGTCCCAGCTACTCGGGATGCTGAGGCAGGAGAAT... |
Task1_train_12717 | An alteration has been detected in RIGI (RNA sensor RIG-I) on Chromosome 9. Is it pathogenic, and if so, what disease is involved? | Pathogenic; Singleton-Merten syndrome 2 | CCATTTATCAATATATTATTTCAGCCTAATTATTAATTGCCTGCAATGTGCCATGCTTTGATTATAGACAGTTGAAAGAACACACTTCATGCTCCATACAGGGCTGTGATCTTAAGGGAGAGAAATATACATGGCTAACTAACCGTAGCAGTTCTCTAACAGAAGTACATGTAAAGTGTAGCCGGGTGTGGTGGCTCACACCTGTAATCCTAACACTTTGGGAGGCCGAGGAGGGTGGATCACTTGAGGTCAGGAATTCAAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTGTACTAAAAATACAAAAAATTAGCCA... | CCATTTATCAATATATTATTTCAGCCTAATTATTAATTGCCTGCAATGTGCCATGCTTTGATTATAGACAGTTGAAAGAACACACTTCATGCTCCATACAGGGCTGTGATCTTAAGGGAGAGAAATATACATGGCTAACTAACCGTAGCAGTTCTCTAACAGAAGTACATGTAAAGTGTAGCCGGGTGTGGTGGCTCACACCTGTAATCCTAACACTTTGGGAGGCCGAGGAGGGTGGATCACTTGAGGTCAGGAATTCAAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTGTACTAAAAATACAAAAAATTAGCCA... |
Task1_train_12718 | The gene RIGI (RNA sensor RIG-I) is located on Chromosome 9, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Singleton-Merten syndrome 2 | ACTTACAAGCAGCCTTCAAAAAGGAACTTATCTACACCACTCCCTATTACATGTCTATTTGTTCTACCTCAGAAATACAGTCACATACTACTCAGAGAGCAAGGGTGAAGTCATATATATTTTCTGTATCCCTCTCTTCCTTTCAGGGTTAGTGTAATAATAACATCAATAAACAACTGTTAGTCATATTAAAAAATCATATCTGATCTTTGGAGGAGTGACATCATGAATTCAGATCATTCCATTTCAACTAAAATGATCAAATACATATTCAAACAGTGATGACCACACAGGCACAGAGCATGGGAAAAGGCTGAGTG... | ACTTACAAGCAGCCTTCAAAAAGGAACTTATCTACACCACTCCCTATTACATGTCTATTTGTTCTACCTCAGAAATACAGTCACATACTACTCAGAGAGCAAGGGTGAAGTCATATATATTTTCTGTATCCCTCTCTTCCTTTCAGGGTTAGTGTAATAATAACATCAATAAACAACTGTTAGTCATATTAAAAAATCATATCTGATCTTTGGAGGAGTGACATCATGAATTCAGATCATTCCATTTCAACTAAAATGATCAAATACATATTCAAACAGTGATGACCACACAGGCACAGAGCATGGGAAAAGGCTGAGTG... |
Task1_train_12719 | A mutation on Chromosome 9 affecting APTX (aprataxin) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | CTCACAACTTGAGTGAAAAGTCACATCCCCAAAGATATCCACAATTTCATCAAACCCAACTTTTTAGTTTTCCCTTCACCTTTAGTTCTAATATTATCCCAAAAAACAACTGAATACAACTGTTTTATCCAAATTTATTCTCAGGGAAAAAGAAAGTAGTGGCTCTACGCAACTTTTTCATTCACCAACCACCTTTCCATGCATCAGAACCTATGCTGTGATTGTTAGCTGAACTTCAATAGTTTCCACCTACTTAAGAGAGATGCCTCAAACAAATTAACTTTATTTTCAGACAACAGGTCCAAGAAGACTTCACAGCT... | CTCACAACTTGAGTGAAAAGTCACATCCCCAAAGATATCCACAATTTCATCAAACCCAACTTTTTAGTTTTCCCTTCACCTTTAGTTCTAATATTATCCCAAAAAACAACTGAATACAACTGTTTTATCCAAATTTATTCTCAGGGAAAAAGAAAGTAGTGGCTCTACGCAACTTTTTCATTCACCAACCACCTTTCCATGCATCAGAACCTATGCTGTGATTGTTAGCTGAACTTCAATAGTTTCCACCTACTTAAGAGAGATGCCTCAAACAAATTAACTTTATTTTCAGACAACAGGTCCAAGAAGACTTCACAGCT... |
Task1_train_12720 | A genomic change on Chromosome 9 affects APTX (aprataxin). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; not provided | GAGCATTCTCCTTAGCACGACAACATTCACTGTAGGAAAAAGGTATGGGCATCACGATCACTACGTGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGC... | GAGCATTCTCCTTAGCACGACAACATTCACTGTAGGAAAAAGGTATGGGCATCACGATCACTACGTGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGC... |
Task1_train_12721 | A variant found in Chromosome 9 affects APTX (aprataxin). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | ATCACGATCACTACGTGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGCGTGATCATAGCTTACTGTAGCCTCAACCTCCTGGGCTCAAGTGATCCTTC... | ATCACGATCACTACGTGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGCGTGATCATAGCTTACTGTAGCCTCAACCTCCTGGGCTCAAGTGATCCTTC... |
Task1_train_12722 | This gene mutation involves APTX (aprataxin) on Chromosome 9. Is it associated with any clinical condition, or is it benign? | Pathogenic; Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | TGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGCGTGATCATAGCTTACTGTAGCCTCAACCTCCTGGGCTCAAGTGATCCTTCCAACTCAACCTCCCA... | TGAAAAGGGCTCAGTGGCCAAGGGCTCTGTTAGTCAGGGGCTCTGCATTAGGGAAACAGGATTATGGGTGACTTTCCCTCCTAAATTTTCAAATCAGCCTTTAACAATAAAAATATATTTATATTTTTAAAGTGAGGTACAACATACATCCACCCTATGACCTAACAATTCCATCTCCAAATATTTATTCTTTTTTTTTCTTCTTCTTTTTTGAGACAGAGTCTCACTCTGTTGCCCAGGCTGGAGTACAATGGCGTGATCATAGCTTACTGTAGCCTCAACCTCCTGGGCTCAAGTGATCCTTCCAACTCAACCTCCCA... |
Task1_train_12723 | Located on Chromosome 9, this mutation impacts B4GALT1 (beta-1,4-galactosyltransferase 1). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; Combined low LDL and fibrinogen | AACCTGAGCCCAGGCTGGACCTGGCAAAGGCGCTCAGTGGTAGGAGTGCCTTGTGTCATCTCATCCCAGGTGGCTCAATAGCTCCCAACAGAGGTGGGTTTGTGACAGACAGCCCTGTGGGTGGGAGCCTCAACTGGGGTGGGAGCACCTGTGAAAACCTGAGGTGGAACAGGAGGCTTTAGGCACCGAAGTTCTTGGGAGGGAGTTGGGGTGTGGGTTCGGCTGAACTTCTTTCTAGATCACTAATTAAAAGGCACATTCATGCTGGGGAATGGATAGTCTGTTTGACCCTGAGTGCCACAGTCAAGTTTTAGGGGACA... | AACCTGAGCCCAGGCTGGACCTGGCAAAGGCGCTCAGTGGTAGGAGTGCCTTGTGTCATCTCATCCCAGGTGGCTCAATAGCTCCCAACAGAGGTGGGTTTGTGACAGACAGCCCTGTGGGTGGGAGCCTCAACTGGGGTGGGAGCACCTGTGAAAACCTGAGGTGGAACAGGAGGCTTTAGGCACCGAAGTTCTTGGGAGGGAGTTGGGGTGTGGGTTCGGCTGAACTTCTTTCTAGATCACTAATTAAAAGGCACATTCATGCTGGGGAATGGATAGTCTGTTTGACCCTGAGTGCCACAGTCAAGTTTTAGGGGACA... |
Task1_train_12724 | Here is a mutation in KIF24 (kinesin family member 24) on Chromosome 9. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Asphyxiating thoracic dystrophy 3 | GTGCTGACTCTTCTGGCTTTTTTTTGGCCACATGTCCAGAGCGCACAGTTCCTTTCACAGGGCTAGCATGAATGACCCACTCTTGTGAAGGACTCCCTCTGGAGCCACCCCTTTTACCAGAGACCTTAGGTGCAGAAGTAAAAGGAATGTTGGGTGGGTGGCTGGTCAGAGGATGGACCTTCCCTCTCGTGGAACCAGGGGCTGCCACTGTGAGTGACTGCTGAAATCCCAGCTTGACTTTTTTGGGAGAACATTTGTCCTCTGACAAAGCCCCAGGGGAGCTCTGAATTCGTTTTGGAGAGGAGTTTCCAGATGTCCGA... | GTGCTGACTCTTCTGGCTTTTTTTTGGCCACATGTCCAGAGCGCACAGTTCCTTTCACAGGGCTAGCATGAATGACCCACTCTTGTGAAGGACTCCCTCTGGAGCCACCCCTTTTACCAGAGACCTTAGGTGCAGAAGTAAAAGGAATGTTGGGTGGGTGGCTGGTCAGAGGATGGACCTTCCCTCTCGTGGAACCAGGGGCTGCCACTGTGAGTGACTGCTGAAATCCCAGCTTGACTTTTTTGGGAGAACATTTGTCCTCTGACAAAGCCCCAGGGGAGCTCTGAATTCGTTTTGGAGAGGAGTTTCCAGATGTCCGA... |
Task1_train_12725 | This alteration in DNAI1 (dynein axonemal intermediate chain 1) on Chromosome 9 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; Primary ciliary dyskinesia | GTGTCAGAGATATATGGGGGAGGCCAGAGAGGTTGTGTTAGATCTCAAATGCCAGGCTGAGGCAGAAGGAGTTTGTTCTGTTGGCAGTGGTGAGCCATGGAAGGTTTTGGAGCCAAGGAGAGGACTGTCTGTTCTAAGAAGATTGGGCTCCTGTCCCACAGCACAGGCTTCTTCTCCAGGGAACCTGCCTGAGTAGCCAGCTCTGTGCAGGCCCTACTGTGAAGCTTCAACCAGCAACACTCTGTGGGGTGTGTGTGTGTGTGCGTGCTGGTGCAATTCTGGGGAAGGAGGCAGGAAGGATGTACGAGCAAGAGACTAGG... | GTGTCAGAGATATATGGGGGAGGCCAGAGAGGTTGTGTTAGATCTCAAATGCCAGGCTGAGGCAGAAGGAGTTTGTTCTGTTGGCAGTGGTGAGCCATGGAAGGTTTTGGAGCCAAGGAGAGGACTGTCTGTTCTAAGAAGATTGGGCTCCTGTCCCACAGCACAGGCTTCTTCTCCAGGGAACCTGCCTGAGTAGCCAGCTCTGTGCAGGCCCTACTGTGAAGCTTCAACCAGCAACACTCTGTGGGGTGTGTGTGTGTGTGCGTGCTGGTGCAATTCTGGGGAAGGAGGCAGGAAGGATGTACGAGCAAGAGACTAGG... |
Task1_train_12726 | Chromosome 9 houses a mutation in gene DNAI1 (dynein axonemal intermediate chain 1). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Kartagener syndrome | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... |
Task1_train_12727 | Gene DNAI1 (dynein axonemal intermediate chain 1) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Primary ciliary dyskinesia | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... |
Task1_train_12728 | This genomic variant is located on Chromosome 9, within the DNAI1 (dynein axonemal intermediate chain 1) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; DNAI1-related disorder | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... | GGCCTGGCCAGGTCATTCAGGCCCAGTGAGGGTCAGTGACAGTGGTCCTTCCCCTGACTGAGTGCTCCCTCCCCAACCTGTGCCAGGGCCTGACAGGAGATTGTAGGAAGGCCCGGCCCTGTCTGCTGAACCCTTGGCTGTTTGTAGACCCTCCCTGTTTATGCAGTTCCCATCCCTGTGTTTGCAGACCCTGTTCCTGTTTATGCAGATCAGGTGCTGTTATGCAGATCCAGCCCTGTTTATGCAGATCAGGCCCCTGTTTACCCAGATCCTGTCCCTGTTTACTCAATTCCTACCCTGTTTATGCAGACTATATCCCT... |
Task1_train_12729 | Assess the clinical impact of this variant on gene SIGMAR1 (sigma non-opioid intracellular receptor 1), found on Chromosome 9. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; Amyotrophic lateral sclerosis type 16 | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... |
Task1_train_12730 | A variant affecting Chromosome 9, within the gene SIGMAR1 (sigma non-opioid intracellular receptor 1), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Autosomal recessive distal spinal muscular atrophy 2 | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... |
Task1_train_12731 | This alteration in SIGMAR1 (sigma non-opioid intracellular receptor 1) on Chromosome 9 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; Inborn genetic diseases | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... | GTCAGACTGAGGCAGTATAATACCCTCCCCCATCCTTAACTCTAGAACCCCGGTTTGGTGGGGAGGAGGTGGGAAGCTGTGGAGCTATGGAAAGGCCTCAGTTAGTGAGTCAAGCTGTGATGTGTGTGTCTGAACACAACTGGCTCCCTTGGTATACCGGGGGCTCCCTCTCCAGATGGGTGTGAGTGCATGGTCCTACTGTACACACAGGTCTCAGTATCTATATGTGTCTCATTTGTTCCCATGGGTCTCTGTGTTTGGATACATAAGCATGGATATCCCTGCTCATACAGCAGGAACTCAGGATCTGCATGGTGTAT... |
Task1_train_12732 | A sequence alteration has been identified in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | AGATGTTCCTGATGGGGGTCAGGATTTAATTAGCATGATTCAGGGGGCGGCACTGAAGCACTGGTGTTCTTGGGAAAATGGAGCTGTCTACAAGCTCTAGTCACTCAAACAAATATAAATGAGAGAATGGAAAAGCAGATCTCCTGTTCCTGTCTCACCTCTTTGGGTAATATGAACAGCCAGTGGGACAGGTAAAACCCCTGTTTCTCAGTCCTCAGCTCCCTGCCCCCTACCTCTGAAGGTAGCCTCTTCCTATTCCAGTCTGAGGACCCTAGGGCAGAGATCAAGTAAATGACCCATGACCTAGTTTTTGCAGCTCA... | AGATGTTCCTGATGGGGGTCAGGATTTAATTAGCATGATTCAGGGGGCGGCACTGAAGCACTGGTGTTCTTGGGAAAATGGAGCTGTCTACAAGCTCTAGTCACTCAAACAAATATAAATGAGAGAATGGAAAAGCAGATCTCCTGTTCCTGTCTCACCTCTTTGGGTAATATGAACAGCCAGTGGGACAGGTAAAACCCCTGTTTCTCAGTCCTCAGCTCCCTGCCCCCTACCTCTGAAGGTAGCCTCTTCCTATTCCAGTCTGAGGACCCTAGGGCAGAGATCAAGTAAATGACCCATGACCTAGTTTTTGCAGCTCA... |
Task1_train_12733 | This variant affects gene GALT (galactose-1-phosphate uridylyltransferase) located on Chromosome 9. Evaluate its biological effect and specify any disease association. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GATGTTCCTGATGGGGGTCAGGATTTAATTAGCATGATTCAGGGGGCGGCACTGAAGCACTGGTGTTCTTGGGAAAATGGAGCTGTCTACAAGCTCTAGTCACTCAAACAAATATAAATGAGAGAATGGAAAAGCAGATCTCCTGTTCCTGTCTCACCTCTTTGGGTAATATGAACAGCCAGTGGGACAGGTAAAACCCCTGTTTCTCAGTCCTCAGCTCCCTGCCCCCTACCTCTGAAGGTAGCCTCTTCCTATTCCAGTCTGAGGACCCTAGGGCAGAGATCAAGTAAATGACCCATGACCTAGTTTTTGCAGCTCAA... | GATGTTCCTGATGGGGGTCAGGATTTAATTAGCATGATTCAGGGGGCGGCACTGAAGCACTGGTGTTCTTGGGAAAATGGAGCTGTCTACAAGCTCTAGTCACTCAAACAAATATAAATGAGAGAATGGAAAAGCAGATCTCCTGTTCCTGTCTCACCTCTTTGGGTAATATGAACAGCCAGTGGGACAGGTAAAACCCCTGTTTCTCAGTCCTCAGCTCCCTGCCCCCTACCTCTGAAGGTAGCCTCTTCCTATTCCAGTCTGAGGACCCTAGGGCAGAGATCAAGTAAATGACCCATGACCTAGTTTTTGCAGCTCAA... |
Task1_train_12734 | A mutation found in LOC130001683, GALT (ATAC-STARR-seq lymphoblastoid active region 28314| galactose-1-phosphate uridylyltransferase) on Chromosome 9 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TCCACTGAAGCCTCAGAGGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAG... | TCCACTGAAGCCTCAGAGGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAG... |
Task1_train_12735 | This is a variant in GALT, LOC130001683 (galactose-1-phosphate uridylyltransferase| ATAC-STARR-seq lymphoblastoid active region 28314), located on Chromosome 9. Is this mutation a likely cause of disease or not? | Pathogenic; not provided | TGAAGCCTCAGAGGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGA... | TGAAGCCTCAGAGGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGA... |
Task1_train_12736 | This sequence variant lies in GALT, LOC130001683 (galactose-1-phosphate uridylyltransferase| ATAC-STARR-seq lymphoblastoid active region 28314) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATC... | GGCATCTCACAGCACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATC... |
Task1_train_12737 | A mutation found in GALT, LOC130001683 (galactose-1-phosphate uridylyltransferase| ATAC-STARR-seq lymphoblastoid active region 28314) on Chromosome 9 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | CACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGG... | CACTGGGAAAAGCCTTGGAAACTTGCATTCAAATCTCAGCTTGGCCACTAATTCTCTGGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGG... |
Task1_train_12738 | This sequence change occurs on Chromosome 9, altering GALT, LOC130001683 (galactose-1-phosphate uridylyltransferase| ATAC-STARR-seq lymphoblastoid active region 28314). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGTGGAGGTTGCAGTGAGCCAAGATCACGCCACTGCACTCCAGCCTGGGTGGCAG... | GGGTGACCTTGAGTCCTCTGGGCTCCAATGTGAAATGGGGAAGAGGTTTAGACAATATTTAGATGGCTCTTTAAAAGTACTGGGGGCCAGCTGTTTGGGAGGCTGAGGCAGGAGGATCACTTGAAGTCAGGAGTTCAAGACCAGCCTGGCCAACATGTGAAACCCCGTCTCTACTAAAAATACATAAATTAGCCCAGTGTGGTGGCACACAGCTCTAATTCCAGCTACTTGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGTGGAGGTTGCAGTGAGCCAAGATCACGCCACTGCACTCCAGCCTGGGTGGCAG... |
Task1_train_12739 | A variant was discovered in gene GALT (galactose-1-phosphate uridylyltransferase), Chromosome 9. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; not specified | GCACTCCAGCCTGGGTGGCAGAGTGAGACTCTCTCTCAAACAAACAAACAAACAAAAGTACCAGGGGAGGAATTAATTTGAATTTTATCCTAGTGTTAGCCAATTGGTCCCATCCAAGGAAAATTTAGAAAAGGGAAGGGGATGTGTAAAGGAAACACTAGGCCCCACCTAGATGGTGGCTGGAGCTTCTGATAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTG... | GCACTCCAGCCTGGGTGGCAGAGTGAGACTCTCTCTCAAACAAACAAACAAACAAAAGTACCAGGGGAGGAATTAATTTGAATTTTATCCTAGTGTTAGCCAATTGGTCCCATCCAAGGAAAATTTAGAAAAGGGAAGGGGATGTGTAAAGGAAACACTAGGCCCCACCTAGATGGTGGCTGGAGCTTCTGATAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTG... |
Task1_train_12740 | A genetic alteration is present in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GCACTCCAGCCTGGGTGGCAGAGTGAGACTCTCTCTCAAACAAACAAACAAACAAAAGTACCAGGGGAGGAATTAATTTGAATTTTATCCTAGTGTTAGCCAATTGGTCCCATCCAAGGAAAATTTAGAAAAGGGAAGGGGATGTGTAAAGGAAACACTAGGCCCCACCTAGATGGTGGCTGGAGCTTCTGATAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTG... | GCACTCCAGCCTGGGTGGCAGAGTGAGACTCTCTCTCAAACAAACAAACAAACAAAAGTACCAGGGGAGGAATTAATTTGAATTTTATCCTAGTGTTAGCCAATTGGTCCCATCCAAGGAAAATTTAGAAAAGGGAAGGGGATGTGTAAAGGAAACACTAGGCCCCACCTAGATGGTGGCTGGAGCTTCTGATAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTG... |
Task1_train_12741 | Consider a variant on Chromosome 9 in gene GALT (galactose-1-phosphate uridylyltransferase). Determine its clinical classification and disease relevance. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGGTGGGACTACAGGTGCACGCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCG... | TAGTCCTGTACTCTCCACATTTTTAGACTTTCTTGTACTTTTTTTTTTTTTTTTGTGACGGAGTCTGCTCTGTCGCCAGGCTAGAGTGCATGGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGGTGGGACTACAGGTGCACGCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCG... |
Task1_train_12742 | A variant was discovered on Chromosome 9, affecting GALT (galactose-1-phosphate uridylyltransferase). What is its functional impact — neutral or pathogenic? State the disease if pathogenic. | Pathogenic; not provided | CTGCCTCAGCCTCCCGAGTAGGTGGGACTACAGGTGCACGCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGG... | CTGCCTCAGCCTCCCGAGTAGGTGGGACTACAGGTGCACGCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGG... |
Task1_train_12743 | Gene GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... |
Task1_train_12744 | This gene mutation involves GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is it associated with any clinical condition, or is it benign? | Pathogenic; GALT-related disorder | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... |
Task1_train_12745 | The gene GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... | GCCACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGG... |
Task1_train_12746 | Gene GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | ACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGA... | ACCAAGACCAGCTAATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGA... |
Task1_train_12747 | With a mutation on Chromosome 9 in gene GALT (galactose-1-phosphate uridylyltransferase), classify this variant as benign or pathogenic. Include the disease if it's pathogenic. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | ATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTAT... | ATTTTTTTTTTTTTTTTTTTTACTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATTTCTTGACCTTGTGATCCGCCTGCCTTGGTCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGAGCCCGGCCATTTTTAGATTTTTTTTTATAGCCCTTTTACCCCTCCCACTTCTTGTGCTGTCTTGGTGTGTGTATGAAAAAGAGAGAGAGAGAGAGAGGAAGGAGAGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTAT... |
Task1_train_12748 | Here is a variant affecting GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | AGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGA... | AGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGA... |
Task1_train_12749 | Assess the clinical impact of this variant on gene GALT (galactose-1-phosphate uridylyltransferase), found on Chromosome 9. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; not specified | AGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGA... | AGCAAGAGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGA... |
Task1_train_12750 | Consider this mutation in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is this a benign change or a disease-causing variant? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | AGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAG... | AGTGAGAGAAAAAGAGAATATGGTTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAG... |
Task1_train_12751 | This alteration occurs within gene GALT (galactose-1-phosphate uridylyltransferase) located on Chromosome 9. Is it associated with a disease or is it a benign variant? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCT... | TTACTTAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCT... |
Task1_train_12752 | The gene GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGC... | TAGCCCTTTTTCCCAAATCTGTTTTTGCTTTTGGGGATAGGATATGGTTATGGTGAAGTACTCCACACAGACCCCACCAAGTTTGCCTCTCCTGCGCTACAGCCACTGAGCAGGTGACTGAGGCGCTGTTGATCCAGGGTCATATCCTTACTCGCCCTAGAATGTAAGCTCAGGCAGGGCAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGC... |
Task1_train_12753 | Given this context: Chromosome 9, gene GALT (galactose-1-phosphate uridylyltransferase) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | CAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGG... | CAGAGGCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGG... |
Task1_train_12754 | Given this variant in gene GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCG... | GCCATGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCG... |
Task1_train_12755 | Here’s a variant in GALT (galactose-1-phosphate uridylyltransferase) located on Chromosome 9. What is the predicted biological effect — harmless or disease-causing? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGC... | TGCCTGACATGTGCATCCCAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGC... |
Task1_train_12756 | Consider this mutation in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is this a benign change or a disease-causing variant? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | CAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGA... | CAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGA... |
Task1_train_12757 | An alteration has been detected in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is it pathogenic, and if so, what disease is involved? | Pathogenic; Galactosemia | CAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGA... | CAATGCTTTACACAGCCTAGGTGCCTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGA... |
Task1_train_12758 | Assess the clinical impact of this variant on gene GALT (galactose-1-phosphate uridylyltransferase), found on Chromosome 9. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | CTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGACGGAGAAAGTGAAAGGTGAGGCAC... | CTAGCACATGCTAGATGCTTGGTAAATATTTGCTGAATGAAAGATCAAATGAATGATTGCAGCAAGCAAGTCCTGTAGGCATCCTGGAGCCCAAGGATTCTGCAGTAGGCAGCTTTCACAGAGGTTCTTCCAGTGTAGTGGCTCTAGCTCTGGGTGAAGTAGGATCATCAATGTCGGCCCCCAGGGTTCACAGCTGTTCTGAGCCCCGCCCCCAGGTGGCAGGGCAGCCCAGTCAGTCAGTCACGTGCTGGCGGCTGGCCAATCATCGGGGGCGGCGCGGGGAGGGGTGGTGTGGACGGAGAAAGTGAAAGGTGAGGCAC... |
Task1_train_12759 | This sequence variant lies in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; not specified | TTCCGGGCAAACGGTAACTGCACCGCGGCAGGGACTCGCTGGGGCGCGGAGCCGAGCCCTCCCCTTCCTTAGGAAGCTTTCGTCCCCTCCGAAGGTTGGAACGCTCATCCCGAGCCAGACCGACAAGGCGTACAGTCTGCAGGCCTGTACGAGCAGCAGGCCAATTGGCGCTGGGAAAGTCCAATCCTGGGCCTCTAGCTCCTGAGCGGGACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCAT... | TTCCGGGCAAACGGTAACTGCACCGCGGCAGGGACTCGCTGGGGCGCGGAGCCGAGCCCTCCCCTTCCTTAGGAAGCTTTCGTCCCCTCCGAAGGTTGGAACGCTCATCCCGAGCCAGACCGACAAGGCGTACAGTCTGCAGGCCTGTACGAGCAGCAGGCCAATTGGCGCTGGGAAAGTCCAATCCTGGGCCTCTAGCTCCTGAGCGGGACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCAT... |
Task1_train_12760 | This sequence variant lies in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TCCTTAGGAAGCTTTCGTCCCCTCCGAAGGTTGGAACGCTCATCCCGAGCCAGACCGACAAGGCGTACAGTCTGCAGGCCTGTACGAGCAGCAGGCCAATTGGCGCTGGGAAAGTCCAATCCTGGGCCTCTAGCTCCTGAGCGGGACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCG... | TCCTTAGGAAGCTTTCGTCCCCTCCGAAGGTTGGAACGCTCATCCCGAGCCAGACCGACAAGGCGTACAGTCTGCAGGCCTGTACGAGCAGCAGGCCAATTGGCGCTGGGAAAGTCCAATCCTGGGCCTCTAGCTCCTGAGCGGGACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCG... |
Task1_train_12761 | A mutation in GALT (galactose-1-phosphate uridylyltransferase), located on Chromosome 9, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | ACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGT... | ACAGGGCCGAGAGGGCGCTCCCGAGCTTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGT... |
Task1_train_12762 | This sequence change occurs on Chromosome 9, altering GALT (galactose-1-phosphate uridylyltransferase). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGTAGTTCCCTCTTAGAACTGTCCTCCAC... | TTGGGCCTGCTGGTGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGTAGTTCCCTCTTAGAACTGTCCTCCAC... |
Task1_train_12763 | A variant found in Chromosome 9 affects GALT (galactose-1-phosphate uridylyltransferase). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGTAGTTCCCTCTTAGAACTGTCCTCCACCCACAGGGATAGT... | TGGGTGAGACCCAGGAGAGAGGGAGCTAGAGAGCTCTGAGGACTGATCTTGACTGTCTGCCCCCAGACCATCAGCATATCCGCTACAACCCGCTGCAGGATGAGTGGGTGCTGGTGTCAGCTCACCGCATGAAGCGGCCCTGGCAGGGTCAAGTGGAGCCCCAGCTTCTGAAGACAGTGCCCCGCCATGACCCTCTCAACCCTCTGTGTCCTGGGGCCATCCGAGCCAACGGAGAGGTAAGCCTGTAGAGCCCTGCATCTGCAGGCTGGGCCACGGGGAGTAGTTCCCTCTTAGAACTGTCCTCCACCCACAGGGATAGT... |
Task1_train_12764 | This mutation occurs in GALT (galactose-1-phosphate uridylyltransferase) on Chromosome 9. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | TGGGGCAGTGAGTGCTTCTAGCCTATCCTTGTCGGTAGGTGAATCCCCAGTACGATAGCACCTTCCTGTTTGACAACGACTTCCCAGCTCTGCAGCCTGATGCCCCCAGTCCAGGTAACCTGGCTCCAACTGCTGCTGGGGAGGAGGGTGGCTAGACCTCTTGAGGGACTTCTGCTGCAGAGAGTGATACTCCTTTACCTCAGGACCCAGTGATCATCCCCTTTTCCAAGCAAAGTCTGCTCGAGGAGTCTGGTAACTATGGATTTCCCCTCTTACAACTTTCAAACCAGAGTTGGAGACTCAGCATTGGGGTTCGGCCC... | TGGGGCAGTGAGTGCTTCTAGCCTATCCTTGTCGGTAGGTGAATCCCCAGTACGATAGCACCTTCCTGTTTGACAACGACTTCCCAGCTCTGCAGCCTGATGCCCCCAGTCCAGGTAACCTGGCTCCAACTGCTGCTGGGGAGGAGGGTGGCTAGACCTCTTGAGGGACTTCTGCTGCAGAGAGTGATACTCCTTTACCTCAGGACCCAGTGATCATCCCCTTTTCCAAGCAAAGTCTGCTCGAGGAGTCTGGTAACTATGGATTTCCCCTCTTACAACTTTCAAACCAGAGTTGGAGACTCAGCATTGGGGTTCGGCCC... |
Task1_train_12765 | Gene GALT (galactose-1-phosphate uridylyltransferase), found on Chromosome 9, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | GCAGTGAGTGCTTCTAGCCTATCCTTGTCGGTAGGTGAATCCCCAGTACGATAGCACCTTCCTGTTTGACAACGACTTCCCAGCTCTGCAGCCTGATGCCCCCAGTCCAGGTAACCTGGCTCCAACTGCTGCTGGGGAGGAGGGTGGCTAGACCTCTTGAGGGACTTCTGCTGCAGAGAGTGATACTCCTTTACCTCAGGACCCAGTGATCATCCCCTTTTCCAAGCAAAGTCTGCTCGAGGAGTCTGGTAACTATGGATTTCCCCTCTTACAACTTTCAAACCAGAGTTGGAGACTCAGCATTGGGGTTCGGCCCTGCC... | GCAGTGAGTGCTTCTAGCCTATCCTTGTCGGTAGGTGAATCCCCAGTACGATAGCACCTTCCTGTTTGACAACGACTTCCCAGCTCTGCAGCCTGATGCCCCCAGTCCAGGTAACCTGGCTCCAACTGCTGCTGGGGAGGAGGGTGGCTAGACCTCTTGAGGGACTTCTGCTGCAGAGAGTGATACTCCTTTACCTCAGGACCCAGTGATCATCCCCTTTTCCAAGCAAAGTCTGCTCGAGGAGTCTGGTAACTATGGATTTCCCCTCTTACAACTTTCAAACCAGAGTTGGAGACTCAGCATTGGGGTTCGGCCCTGCC... |
Task1_train_12766 | A change on Chromosome 9 affects gene IL11RA (interleukin 11 receptor subunit alpha). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Craniosynostosis and dental anomalies | GAGATAGGAGCTGAAGAAGGAAAGGAAGGCAAGGGCTGGCTCACAAGGGGCTTTGAAAGCCAGTAAAAGGAATTTGGGTTCTATTGCAAATGCAGTTAGAAGCCAATGGAGAGCTGTGGCATGGTCTGACTTATGCTTGACATCTTGTCTTTGTCCATTGTCACCTCATCTCACTTCCAGGGACCCAGTGTCCTGGTTTCGGGATGGGGAGCCAAAGCTGCTCCAGGGACCTGACTCTGGGCTAGGGCATGAACTGGTCCTGGCCCAGGCAGACAGCACTGATGAGGGCACCTACATCTGCCAGACCCTGGATGGTGCAC... | GAGATAGGAGCTGAAGAAGGAAAGGAAGGCAAGGGCTGGCTCACAAGGGGCTTTGAAAGCCAGTAAAAGGAATTTGGGTTCTATTGCAAATGCAGTTAGAAGCCAATGGAGAGCTGTGGCATGGTCTGACTTATGCTTGACATCTTGTCTTTGTCCATTGTCACCTCATCTCACTTCCAGGGACCCAGTGTCCTGGTTTCGGGATGGGGAGCCAAAGCTGCTCCAGGGACCTGACTCTGGGCTAGGGCATGAACTGGTCCTGGCCCAGGCAGACAGCACTGATGAGGGCACCTACATCTGCCAGACCCTGGATGGTGCAC... |
Task1_train_12767 | The gene IL11RA (interleukin 11 receptor subunit alpha) is located on Chromosome 9, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; not provided | CTGCTGCTACCCACACTGCCTGATTGGCTGCCTAGCCTCAGAGCAGGCCCTGTACCGAATGCAGCCATATGTCATGTCCTCCCTTGCTGGCCCCTCCTTCCTTGACCTGTGCATGGGAGTGGGACACTAAAACTCTAGCTGGAATTTGGGCCAATTCATCTTCCTTGGATGAAAATAGGAATTGCTCTTTTATTCACTCAAGAAGCACTTCAAAAGTCCACCCGCAGATCTCAGGTGGTTTCTTTTTTTCTTTCTCTTCCTTTTTTTGTTGAGATAGGGTCTCACTTTGTGCCCAGGCTGGATGAAGTTCAGTGGTGTGA... | CTGCTGCTACCCACACTGCCTGATTGGCTGCCTAGCCTCAGAGCAGGCCCTGTACCGAATGCAGCCATATGTCATGTCCTCCCTTGCTGGCCCCTCCTTCCTTGACCTGTGCATGGGAGTGGGACACTAAAACTCTAGCTGGAATTTGGGCCAATTCATCTTCCTTGGATGAAAATAGGAATTGCTCTTTTATTCACTCAAGAAGCACTTCAAAAGTCCACCCGCAGATCTCAGGTGGTTTCTTTTTTTCTTTCTCTTCCTTTTTTTGTTGAGATAGGGTCTCACTTTGTGCCCAGGCTGGATGAAGTTCAGTGGTGTGA... |
Task1_train_12768 | Given this variant in gene IL11RA (interleukin 11 receptor subunit alpha) on Chromosome 9, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Craniosynostosis syndrome | AGCCTCAGAGCAGGCCCTGTACCGAATGCAGCCATATGTCATGTCCTCCCTTGCTGGCCCCTCCTTCCTTGACCTGTGCATGGGAGTGGGACACTAAAACTCTAGCTGGAATTTGGGCCAATTCATCTTCCTTGGATGAAAATAGGAATTGCTCTTTTATTCACTCAAGAAGCACTTCAAAAGTCCACCCGCAGATCTCAGGTGGTTTCTTTTTTTCTTTCTCTTCCTTTTTTTGTTGAGATAGGGTCTCACTTTGTGCCCAGGCTGGATGAAGTTCAGTGGTGTGATCTTGGCTCACTGAAGCCTGCAACTCCTGGGCT... | AGCCTCAGAGCAGGCCCTGTACCGAATGCAGCCATATGTCATGTCCTCCCTTGCTGGCCCCTCCTTCCTTGACCTGTGCATGGGAGTGGGACACTAAAACTCTAGCTGGAATTTGGGCCAATTCATCTTCCTTGGATGAAAATAGGAATTGCTCTTTTATTCACTCAAGAAGCACTTCAAAAGTCCACCCGCAGATCTCAGGTGGTTTCTTTTTTTCTTTCTCTTCCTTTTTTTGTTGAGATAGGGTCTCACTTTGTGCCCAGGCTGGATGAAGTTCAGTGGTGTGATCTTGGCTCACTGAAGCCTGCAACTCCTGGGCT... |
Task1_train_12769 | A mutation on Chromosome 9 affecting VCP (valosin containing protein) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Global developmental delay | CCTGGATTTCATCCCAGGCCTCCCATTACTGCAGTTTATTGGTCTCCTTGCCCTTCCAATCCAACCTGAGGTAAGATGCTAGGCCATGCTTCCTAAAATTGAGTCACTGCTCTGCTTAAAAACTTGTCAATGCACTCTGGAAAAGGGAAAACTGTAGGGACAGAAATCACATCAGTGATGGGGCTTAAGGAGGGGAGATGTTGACTGAAGTGGCTAAGGAAACTTTTTGAGATAGTAGAAATTTTAAGTCTCAACTGTGGTAGTAGTTATAGAACTTACACACACTTGTCATAAAGCATGGAAATGGTATATAGAAAGAG... | CCTGGATTTCATCCCAGGCCTCCCATTACTGCAGTTTATTGGTCTCCTTGCCCTTCCAATCCAACCTGAGGTAAGATGCTAGGCCATGCTTCCTAAAATTGAGTCACTGCTCTGCTTAAAAACTTGTCAATGCACTCTGGAAAAGGGAAAACTGTAGGGACAGAAATCACATCAGTGATGGGGCTTAAGGAGGGGAGATGTTGACTGAAGTGGCTAAGGAAACTTTTTGAGATAGTAGAAATTTTAAGTCTCAACTGTGGTAGTAGTTATAGAACTTACACACACTTGTCATAAAGCATGGAAATGGTATATAGAAAGAG... |
Task1_train_12770 | An alteration has been detected in VCP (valosin containing protein) on Chromosome 9. Is it pathogenic, and if so, what disease is involved? | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GAGTCACTGCTCTGCTTAAAAACTTGTCAATGCACTCTGGAAAAGGGAAAACTGTAGGGACAGAAATCACATCAGTGATGGGGCTTAAGGAGGGGAGATGTTGACTGAAGTGGCTAAGGAAACTTTTTGAGATAGTAGAAATTTTAAGTCTCAACTGTGGTAGTAGTTATAGAACTTACACACACTTGTCATAAAGCATGGAAATGGTATATAGAAAGAGTGAATTTTATTGTATTTATATCATACCTTAATAAACCTTAATACTTTAAAAGGAAATGCCAATGGCTTTCAGTGCTTACCACATTTGGATTACATCCTAC... | GAGTCACTGCTCTGCTTAAAAACTTGTCAATGCACTCTGGAAAAGGGAAAACTGTAGGGACAGAAATCACATCAGTGATGGGGCTTAAGGAGGGGAGATGTTGACTGAAGTGGCTAAGGAAACTTTTTGAGATAGTAGAAATTTTAAGTCTCAACTGTGGTAGTAGTTATAGAACTTACACACACTTGTCATAAAGCATGGAAATGGTATATAGAAAGAGTGAATTTTATTGTATTTATATCATACCTTAATAAACCTTAATACTTTAAAAGGAAATGCCAATGGCTTTCAGTGCTTACCACATTTGGATTACATCCTAC... |
Task1_train_12771 | Given a variant located on Chromosome 9 and affecting VCP (valosin containing protein), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; not provided | CGGGACTTCTCATCAGGAAGTGGGATGTAGATGAGCTGATCAAGACGGCCAGGTCTGAGGATGGCAGGATCAATGATGTCAGGCCGGTTGGTAGCGCCAATGATGAACACATTTTTTTTTGTGGACATGCCATCCATTTCTGTCAGGATCTGGTTGATGACTCGGTCAGCAGCCCCACCACCATCTCCAATGTTACCTCCACGAGCCTTGGCAATCGAATCCAGCTCATCAAAGAATAGCACACAGGGGGCAGCTTGGCGGGCCTGTAGGAGGAATGGATTGATTCAAGCACTAACAAAACTAGATGTCTCTAGGCAAAC... | CGGGACTTCTCATCAGGAAGTGGGATGTAGATGAGCTGATCAAGACGGCCAGGTCTGAGGATGGCAGGATCAATGATGTCAGGCCGGTTGGTAGCGCCAATGATGAACACATTTTTTTTTGTGGACATGCCATCCATTTCTGTCAGGATCTGGTTGATGACTCGGTCAGCAGCCCCACCACCATCTCCAATGTTACCTCCACGAGCCTTGGCAATCGAATCCAGCTCATCAAAGAATAGCACACAGGGGGCAGCTTGGCGGGCCTGTAGGAGGAATGGATTGATTCAAGCACTAACAAAACTAGATGTCTCTAGGCAAAC... |
Task1_train_12772 | This is a variant in VCP (valosin containing protein), located on Chromosome 9. Is this mutation a likely cause of disease or not? | Pathogenic; not provided | CGCTCCACCTCGCCATGAGTCTGCCAGAACAGGATGTCTGGTCAGAAGTGAAGTCAGGGCCTTTCAACCCCCCTCTATCCCCTCAGGTAAGCTCCTACTTTCTCTCTTTTGGGAGCGATGGCATCTAGCTCATCAATGAAGATGATGGCAGGAGCATTCTTCTCAGCCTCCTCAAAGGCTTTACGAAGGTTGCTCTCAGACTCACCAGCCAATTTGCTCATGATCTCAGGACCTGAAAGGATACAGAATGGAGACAATAACAAAATGATAGTCTTTCCCAATTCCTCCCAAAAATCAGTTATCTTGCTTGTTTGGCCCAG... | CGCTCCACCTCGCCATGAGTCTGCCAGAACAGGATGTCTGGTCAGAAGTGAAGTCAGGGCCTTTCAACCCCCCTCTATCCCCTCAGGTAAGCTCCTACTTTCTCTCTTTTGGGAGCGATGGCATCTAGCTCATCAATGAAGATGATGGCAGGAGCATTCTTCTCAGCCTCCTCAAAGGCTTTACGAAGGTTGCTCTCAGACTCACCAGCCAATTTGCTCATGATCTCAGGACCTGAAAGGATACAGAATGGAGACAATAACAAAATGATAGTCTTTCCCAATTCCTCCCAAAAATCAGTTATCTTGCTTGTTTGGCCCAG... |
Task1_train_12773 | An alteration has been detected in VCP (valosin containing protein) on Chromosome 9. Is it pathogenic, and if so, what disease is involved? | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... |
Task1_train_12774 | A variant was discovered in gene VCP (valosin containing protein), Chromosome 9. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... |
Task1_train_12775 | A mutation in VCP (valosin containing protein), located on Chromosome 9, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... |
Task1_train_12776 | This genomic variant is located on Chromosome 9, within the VCP (valosin containing protein) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... | ACTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAAT... |
Task1_train_12777 | Gene VCP (valosin containing protein) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | CTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATT... | CTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATT... |
Task1_train_12778 | A genomic change on Chromosome 9 affects VCP (valosin containing protein). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Amyotrophic lateral sclerosis type 6 | CTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATT... | CTTGCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATT... |
Task1_train_12779 | A variant was discovered in gene VCP (valosin containing protein), Chromosome 9. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATT... | GCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATT... |
Task1_train_12780 | A mutation found in VCP (valosin containing protein) on Chromosome 9 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | GCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATT... | GCATAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATT... |
Task1_train_12781 | A sequence alteration has been identified in VCP (valosin containing protein) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; not provided | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... |
Task1_train_12782 | A mutation on Chromosome 9 affecting VCP (valosin containing protein) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... |
Task1_train_12783 | Given a variant located on Chromosome 9 and affecting VCP (valosin containing protein), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... | TAGGAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGT... |
Task1_train_12784 | Chromosome 9 houses a mutation in gene VCP (valosin containing protein). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... |
Task1_train_12785 | A genomic change on Chromosome 9 affects VCP (valosin containing protein). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... |
Task1_train_12786 | The variant affects gene VCP (valosin containing protein), which is on Chromosome 9. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... | GAGACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTG... |
Task1_train_12787 | A mutation on Chromosome 9 affecting VCP (valosin containing protein) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... |
Task1_train_12788 | Consider a variant on Chromosome 9 in gene VCP (valosin containing protein). Determine its clinical classification and disease relevance. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... |
Task1_train_12789 | Gene VCP (valosin containing protein) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... |
Task1_train_12790 | This variant affects the gene VCP (valosin containing protein) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Inborn genetic diseases | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... | GACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCC... |
Task1_train_12791 | Gene VCP (valosin containing protein) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | ACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCCA... | ACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCCA... |
Task1_train_12792 | This variant affects gene VCP (valosin containing protein) located on Chromosome 9. Evaluate its biological effect and specify any disease association. | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | ACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCCA... | ACTAAGGGCAGAGAAACTGTAGTCCAAATGCGTTTGAAGATACATGACTAGGGAAAGGCAAGAGGCCATTACACTAAGGGCTCAATTTTAGACAGACCAAGGGCCAAAGACTAGCTAAGCCATTTAAGAGAGCAGGGTCTATTTTCTTCATTGCCAGAGGATCACTCACTCCAGTAATCATGCCCTCCAGAATTTATCACACTGGAATGCTGTTCCTTACAATCATCATTTTTCTTCTTCAACACTACCCTTTCTATGGCCTCATCCACAAGCAGAACATGTAAACTGTCCACATAGAAAATGAAATTATTTGTGTGCCA... |
Task1_train_12793 | A mutation on Chromosome 9 affecting VCP (valosin containing protein) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | GTGTGTATACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGT... | GTGTGTATACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGT... |
Task1_train_12794 | A change on Chromosome 9 affects gene VCP (valosin containing protein). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | GTGTGTATACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGT... | GTGTGTATACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGT... |
Task1_train_12795 | Given a variant located on Chromosome 9 and affecting VCP (valosin containing protein), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | TACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCA... | TACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCA... |
Task1_train_12796 | Here is a variant affecting VCP (valosin containing protein) on Chromosome 9. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | TACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCA... | TACAAATATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCA... |
Task1_train_12797 | This variant affects the gene VCP (valosin containing protein) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | TATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTT... | TATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTT... |
Task1_train_12798 | Consider a variant on Chromosome 9 in gene VCP (valosin containing protein). Determine its clinical classification and disease relevance. | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | TATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTT... | TATATGAAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTT... |
Task1_train_12799 | Chromosome 9 houses a mutation in gene VCP (valosin containing protein). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | AAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTTTGGGAG... | AAAATGAGTCTAGCGGCCGGGCACAGTGGCTCACCTGAGGTCAAGAGTTCGAGACGAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCGGGCGTGGTGGCAGACGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGCACCACTGCGCTCCAGCCTGGGGGACAGCGCGACACTCTGTCTCAAAAAAAAAAGAAAAGAAAATGAGACTAGGCTTGATGGCTCATGCCTGTAATCCCAGCACTTTGGGAG... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.